Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oxindole. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111848322B details a mild resolution method for axially chiral oxindole styrenes using chiral phosphoric acid, offering high enantioselectivity for pharma applications.
Patent CN102659662A reveals a mild base-catalyzed route to 3-hydroxy-2-oxindoles using isatin, offering significant cost reduction and scalability for API manufacturing.
Patent CN113666862A reveals a nickel-catalyzed asymmetric nitration method for chiral 3-nitroindoles, offering high enantioselectivity and cost-effective manufacturing solutions.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediates.
Patent CN102659662A details a mild base-catalyzed synthesis of 3-hydroxy-2-oxindoles from isatin, offering cost-effective routes for pharmaceutical intermediate manufacturing.
Patent CN115215783B reveals novel copper-catalyzed synthesis for chiral oxindoles. Delivers high stereoselectivity and supply chain reliability for pharmaceutical manufacturing.
Patent CN115215783B reveals high-yield copper catalysis for chiral oxindoles. Enables cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.
Patent CN115215783B reveals novel copper-catalyzed synthesis for chiral oxindoles. Enables cost reduction in pharmaceutical intermediate manufacturing with high stereoselectivity.
Novel patent CN121378226A reveals mild synthesis for oxindole compounds. Offers supply chain stability and cost efficiency for pharmaceutical intermediates manufacturing globally.
Patent CN111848322B details a chiral phosphoric acid catalyzed resolution method for axially chiral oxindole-styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Patent CN111848322B details a novel organocatalytic resolution for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Patent CN111777637B discloses a novel oxindole-derived phosphine catalyst enabling mild asymmetric cyclizations with excellent yields and supply chain stability.
Patent CN107602577A details a novel organocatalytic route for chiral oxindole spiropiperidines. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Patent CN111848322B details a novel chiral phosphoric acid resolution method for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical manufacturing.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediates.
Discover novel axial chiral oxindole-derived styrene phosphine catalysts from patent CN111777637B. Enables asymmetric cyclization with mild conditions and scalable synthesis for fine chemical manufacturing.
Patent CN105481867A details a novel three-step relay catalysis method for high-purity chiral spiro-oxindole synthesis, offering significant supply chain and cost advantages for pharmaceutical manufacturing.
Patent CN121378226A reveals a mild synthesis method for oxindole compounds with high yield. This offers cost reduction and supply reliability for pharmaceutical intermediates.